Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Systemic Air Embolism After CT-guided Lung Biopsy: Incidence and Risk Factors Assessment

NCT03360084 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT03360084
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03360084 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Systemic Air Embolism After CT-guided Lung Biopsy: Incidence and Risk Factors Assessment
Lead sponsor
University Hospital, Montpellier
Phase
Observational
Overall status
Completed
Start date
September 30, 2015
Completion date
July 31, 2017
Enrollment
559 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

patients who presented systemic air embolism after percutaneous lung biopsy under ct guidance depicted at the time of the procedure on a whole thoracic ct, patients who underwent percutaneous lung biopsy under ct guidance